よむ、つかう、まなぶ。
参考資料16 新型コロナワクチンの接種について（令和４年11月４日第40回厚生科学審議会予防接種・ワクチン分科会資料１） (38 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/0000208910_00055.html |
| 出典情報 | 第 88 回厚生科学審議会予防接種・ワクチン分科会 副反応検討部会、令和４年度第 18 回薬事・食品衛生審 議会薬事分科会医薬品等安全対策部会安全対策調査会（11／11）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
参考資料一覧（2/5）
武田社ワクチン（ノババックス）に関する諸外国の対応状況
米国
CDC. 2022. CDC Recommends Novavax COVID-19 Vaccine for Adolescents. [online] Available at: <https://www.cdc.gov/media/releases/2022/s0822-novax-vaccine.html> [Accessed 28 October 2022].
CDC. 2022. CDC Allows Novavax Monovalent COVID-19 Boosters for Adults Ages 18 and Older. [online] Available at: <https://www.cdc.gov/media/releases/2022/s1019-novavax.html> [Accessed 28 October
2022].
英国
GOV.UK. 2022. COVID-19: the green book, chapter 14a. [online] Available at: <https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a> [Accessed 28 October 2022].
カナダ
NACI. 2022. Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [online] Available at: <https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/nationaladvisory-committee-on-immunization-naci/recommendations-use-novavax-nuvaxovid-covid-19-vaccine.pdf> [Accessed 28 October 2022].
フランス
Ministère des Solidarités et de la Santé. 2022. DGS-URGENT. [online] Available at: <https://solidarites-sante.gouv.fr/IMG/pdf/dgs-urgent_2022-35_novavax.pdf> [Accessed 28 October 2022].
ドイツ
Zusammengegencorona.de. 2022. Erster „Totimpfstoff“ gegen COVID-19: Alles Wichtige zu Nuvaxovid® von Novavax. [online] Available at:
<https://www.zusammengegencorona.de/impfen/impfstoffe/erster-totimpfstoff-gegen-covid-19-alles-wichtige-zu-nuvaxovid-r-von-novavax/> [Accessed 28 October 2022].
イスラエル
Ministry of Health. 2022. The Novavax COVID-19 Vaccine Will Be Available in HMOs Soon. [online] Available at: < https://www.gov.il/en/departments/news/04092022-02 > [Accessed 28 October 2022].
国際連合
WHO. 2022. Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19. [online] Available at: <https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGErecommendation-novavax-nvx-cov2373> [Accessed 28 October 2022].
EU
European Medicines Agency. 2022. EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17. [online] Available at: <https://www.ema.europa.eu/en/news/ema-recommendsauthorisation-nuvaxovid-adolescents-aged-12-17> [Accessed 28 October 2022].
European Medicines Agency. 2022. Nuvaxovid. [online] Available at: <https://www.ema.europa.eu/en/medicines/human/EPAR/nuvaxovid> [Accessed 28 October 2022].
38
武田社ワクチン（ノババックス）に関する諸外国の対応状況
米国
CDC. 2022. CDC Recommends Novavax COVID-19 Vaccine for Adolescents. [online] Available at: <https://www.cdc.gov/media/releases/2022/s0822-novax-vaccine.html> [Accessed 28 October 2022].
CDC. 2022. CDC Allows Novavax Monovalent COVID-19 Boosters for Adults Ages 18 and Older. [online] Available at: <https://www.cdc.gov/media/releases/2022/s1019-novavax.html> [Accessed 28 October
2022].
英国
GOV.UK. 2022. COVID-19: the green book, chapter 14a. [online] Available at: <https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a> [Accessed 28 October 2022].
カナダ
NACI. 2022. Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [online] Available at: <https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/nationaladvisory-committee-on-immunization-naci/recommendations-use-novavax-nuvaxovid-covid-19-vaccine.pdf> [Accessed 28 October 2022].
フランス
Ministère des Solidarités et de la Santé. 2022. DGS-URGENT. [online] Available at: <https://solidarites-sante.gouv.fr/IMG/pdf/dgs-urgent_2022-35_novavax.pdf> [Accessed 28 October 2022].
ドイツ
Zusammengegencorona.de. 2022. Erster „Totimpfstoff“ gegen COVID-19: Alles Wichtige zu Nuvaxovid® von Novavax. [online] Available at:
<https://www.zusammengegencorona.de/impfen/impfstoffe/erster-totimpfstoff-gegen-covid-19-alles-wichtige-zu-nuvaxovid-r-von-novavax/> [Accessed 28 October 2022].
イスラエル
Ministry of Health. 2022. The Novavax COVID-19 Vaccine Will Be Available in HMOs Soon. [online] Available at: < https://www.gov.il/en/departments/news/04092022-02 > [Accessed 28 October 2022].
国際連合
WHO. 2022. Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19. [online] Available at: <https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGErecommendation-novavax-nvx-cov2373> [Accessed 28 October 2022].
EU
European Medicines Agency. 2022. EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17. [online] Available at: <https://www.ema.europa.eu/en/news/ema-recommendsauthorisation-nuvaxovid-adolescents-aged-12-17> [Accessed 28 October 2022].
European Medicines Agency. 2022. Nuvaxovid. [online] Available at: <https://www.ema.europa.eu/en/medicines/human/EPAR/nuvaxovid> [Accessed 28 October 2022].
38